The Centers for Disease Control and Prevention Feb. 26 announced that an infant botulism outbreak that sickened 48 babies who consumed ByHeart formula is over.
Bridging Nations. Accelerating Therapies for Rare Diseases Together. The organization’s 2030 vision institutionalizes ...
Federal health data shows Black women are more than three times likely than white women to die around the time of childbirth.
For too long, the promise of personalized therapies has been tantalizingly close, yet frustratingly out of reach for ...
Newly published data indicate a quiet shift in hospital nurseries that may signal a broader change in how Americans view ...
New FDA guidelines for personalized genomic drug development are a step forward in advancing new therapies for ultrarare diseases, but industry leaders need further clarification.
A Philadelphia-area woman is among a growing number of younger women with cardiovascular disease. This device saved her life.
One to two out of every 100 newborn babies are born with a Congenital Heart Defect (CHD), yet the exact cause remains unclear ...
A rare outbreak of infant botulism that sickened dozens of babies who drank recalled ByHeart formula is over, with no new ...
The U.S. Centers for Disease Control and Prevention declared the multistate infant botulism outbreak linked to ByHeart ...
While heart disease in younger populations is rising globally, there have been virtually no studies examining parenting while navigating an early-onset cardiovascular condition. To address this gap, ...
Young infants hospitalized with respiratory syncytial virus (RSV) often become much sicker compared to those infected with SARS-CoV-2, the virus that causes COVID-19.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results